These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3743624)

  • 21. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer.
    Rabin HR; Urtasun RC; Partington J; Koziol D; Sharon M; Walker K
    Cancer Treat Rep; 1980; 64(10-11):1087-95. PubMed ID: 7459894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories.
    Bergan T; Arnold E
    Chemotherapy; 1980; 26(4):231-41. PubMed ID: 7389423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
    Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH
    Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition and removal of metronidazole in patients undergoing haemodialysis.
    Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
    Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disposition of [14C]metronidazole in rats following vaginal and oral administration.
    Buttar HS; Siddiqui WH; Moffatt JH
    J Pharm Pharmacol; 1979 Aug; 31(8):542-4. PubMed ID: 39996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and kinetics of amlodipine in man.
    Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronidazole kinetics in dialysis patients.
    Kreeft JH; Ogilvie RI; Dufresne LR
    Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition and induction of metronidazole and antipyrine metabolism.
    Loft S; Sonne J; Poulsen HE; Petersen KT; Jørgensen BG; Døssing M
    Eur J Clin Pharmacol; 1987; 32(1):35-41. PubMed ID: 3582467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of metronidazole and its major metabolite after a high intravenous dose.
    Bergan T; Aase S; Leinebo O; Harbitz T; Olsen A; Liavag I
    Scand J Gastroenterol Suppl; 1984; 91():113-23. PubMed ID: 6588488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of metronidazole and its metabolites in reduced renal function.
    Bergan T; Thorsteinsson SB
    Chemotherapy; 1986; 32(4):305-18. PubMed ID: 3731917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and tissue distribution of metronidazole in the new born infant.
    Jager-Roman E; Doyle PE; Baird-Lambert J; Cvejic M; Buchanan N
    J Pediatr; 1982 Apr; 100(4):651-4. PubMed ID: 7062220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and metabolic disposition of 14C-metronidazole-derived radioactivity in rat after intravenous and intravaginal administration.
    Buttar HS; Siddiqui WH
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):4-19. PubMed ID: 7406601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.
    Bergan T; Leinebo O; Blom-Hagen T; Salvesen B
    Scand J Gastroenterol Suppl; 1984; 91():45-60. PubMed ID: 6588489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.